483 Document: Gelesis, Inc., Jan 25, 2023

FDANews 483 Gelesis, Inc. Jan 25 2023 top
James P. Finn FDA Investigator

On Jan 25, 2023, the FDA inspected Gelesis, Inc.'s Boston site. Explore the inspectional observations.